Abdulaali R. Almutairi, PharmD; Nimer S. Alkhatib, PharmD, MS; Mok Oh, PharmD, MS; et al.
free access
has audio
JAMA Dermatol. 2019;155(1):22-28. doi:10.1001/jamadermatol.2018.3958
This economic evaluation assesses the cost-effectiveness of talimogene laherparepvec plus ipilimumab combination therapy vs ipilimumab monotherapy in patients with advanced unresectable melanoma from the perspective of public and private US payers.
-
Podcast:
Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab vs Ipilimumab Alone for Unresectable Melanoma
Michael D. Tharp, MD; Jonathan A. Bernstein, MD; Abhishek Kavati, PhD; et al.
free access
JAMA Dermatol. 2019;155(1):29-38. doi:10.1001/jamadermatol.2018.3447
This meta-analysis of 67 observational studies analyzes the effectiveness and adverse event rate of omalizumab therapy in patients with chronic idiopathic urticaria and compares these findings with those of randomized clinical trials conducted among similar patients.
Reza Ghiasvand, PhD; Trude E. Robsahm, PhD; Adele C. Green, PhD; et al.
free access
JAMA Dermatol. 2019;155(1):39-49. doi:10.1001/jamadermatol.2018.3964
This population-based cohort study uses data from the Norwegian Women and Cancer study to investigate the association between phenotypic characteristics, pattern of UV radiation exposure, and risk of melanoma on different body sites.
Sunna Thorsteinsdottir, MD; Jakob Stokholm, MD, PhD; Jacob P. Thyssen, MD, PhD; et al.
free access
JAMA Dermatol. 2019;155(1):50-57. doi:10.1001/jamadermatol.2018.4061
This clinical birth cohort study evaluates the association of genetic, environmental, clinical, and social factors with the persistence of atopic dermatitis at age 13 years among children born to parents with asthma.
Philipp Tschandl, MD, PhD; Cliff Rosendahl, PhD; Bengu Nisa Akay, MD; et al.
free access
JAMA Dermatol. 2019;155(1):58-65. doi:10.1001/jamadermatol.2018.4378
This study compares the accuracy of a convolutional neural network鈥揵ased classifier with that of physicians with different levels of experience at classifying dermoscopic and close-up images of nonpigmented lesions.
Joana Lanz, MD; Jan Nico Bouwes Bavinck, MD, PhD; Marlies Westhuis, MD; et al.
free access
JAMA Dermatol. 2019;155(1):66-71. doi:10.1001/jamadermatol.2018.4406
This case series describes the clinicopathologic features of and identifies factors associated with aggressive squamous cell carcinoma in solid organ transplant recipients.
Jennifer Pugh, BS; Sikandar G. Khan, PhD; Deborah Tamura, RN, MS; et al.
free access
JAMA Dermatol. 2019;155(1):72-78. doi:10.1001/jamadermatol.2018.4473
This molecular epidemiologic study examinsd 3 large exome sequence databases totaling more than 200鈥�000 alleles to correlate disease-associated allele frequencies with the expected and reported prevalence of clinical disease.